PhRMA: Need For Long-Term Japan Pharma Policies
This article was originally published in PharmAsia News
Executive Summary
The U.S. industry association PhRMA continues to see substantial progress with regulatory and healthcare reforms in Japan but stresses the remaining need for long-term policies that encourage innovation, foreign investment and the broader use of modern vaccines.